LEE GARY K. (Chief Scientific Officer) sold 9.0% of their position (1.67K shares) of LYELL IMMUNOPHARMA, INC. on the open market
Open‑market sale worth $39.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2026ACC: 0001907345-26-000002
Officer· Chief Scientific Officer
Since Jan 2022
-1.67K
Net shares
Net seller
$39.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.67K
Price / share
$23.39
Trade value
$39.08K
% of position
9.0%
2/11/2026
18.61K→16.94K
Total
Net shares
−1.67K
Net value
-$39.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | S · Sale | −1.67K | $23.39 | $39.08K | 9.0% | 18.61K | 16.94K |
| Total | −1.67K | -$39.08K | ||||||
Derivative Transactions0
No derivative transactions reported